我必须注册中间体吗？

我必须注册中间体吗？

Do I have to register intermediates?

您的中间体是否需要注册取决于REACH法规第3(15)条规定的中间体类型。非分离中间体：对于将物质用作非分离中间体的情况，REACH法规不承担任何义务。现场分离中间体：每年生产 1 吨或以上的现场分离中间体的制造商需要注册其物质（如果这些物质没有获得其他豁免注册（请参阅 FAQ ID=30）。但是，如果现场分离中间体的注册人确认该物质是在 REACH 法规第 17(3) 条所述的严格控制条件下生产和使用的，则可以根据 REACH 法规第 17(2) 条提供减少的注册信息。运输分离中间体：每年生产 1 吨或以上的运输分离中间体的制造商或进口商需要注册其物质（如果这些物质没有获得其他豁免注册）。但是，如果运输分离中间体的注册人确认他在严格控制的条件下生产和/或使用该物质，并且确认或声明他已收到用户的确认，该物质是在 REACH 法规第 18(4) 条所述的严格控制条件下使用的，则可以根据 REACH 法规第 18(2) 条提供减少的注册信息。在这种情况下，注册人和用户均应对其自身关于严格控制条件的声明负责。REACH 法规中关于中间体注册的具体规定何时以及如何适用，请参阅中间体指南：http://echa.europa.eu/guidance-documents/guidance-on-reach。更多信息请访问：http://echa.europa.eu/documents/10162/13655/pg16_intermediate_registration_en.pdf

It depends under which type of intermediate as described under Article 3(15) of the REACH Regulation your intermediate falls, whether you have registration obligations or not. Non-isolated intermediates: For the use of a substance as a non-isolated intermediate, there are no obligations under the REACH Regulation. On-site isolated intermediates: A manufacturer of on-site isolated intermediates in quantities of 1 tonne or more per year needs to register their substances (if they are not otherwise exempted from registration (see FAQ ID=30). However registrants of on-site isolated intermediates can provide reduced registration information according to Article 17(2) of the REACH Regulation if they confirm that the substance is manufactured and used under strictly controlled conditions as described under Article 17(3) of REACH. Transported isolated intermediates: A manufacturer or importer of transported isolated intermediates in quantities of 1 tonne or more per year needs to register his substances if they are not otherwise exempted from registration. However, a registrant of transported isolated intermediates can provide reduced registration information according to Article 18(2) of the REACH Regulation if he confirms that he is manufacturing and/or using the substance under strictly controlled conditions and if he confirms or states that he has received confirmation from the user that the substance is used under strictly controlled conditions as described under Article 18(4) of REACH. In this case, both the registrant and the users are each liable for their own statement regarding the strictly controlled conditions. When and how the specific provisions for the registration of intermediates under REACH can be used are described in the Guidance for intermediates: http://echa.europa.eu/guidance-documents/guidance-on-reach. More information can be found at: http://echa.europa.eu/documents/10162/13655/pg16_intermediate_registration_en.pdf